|
|
||||||||
Molecular Diagnostics and Genetics |
1 Genomic Unit for the Diagnosis of Human Pathologies, San Raffaele Scientific Institute, Milano, Italy; 2 Istituto di Chimica del Riconoscimento Molecolare (ICRM), C.N.R., Milano, Italy; 3 Cardeza Foundation for Hematologic Research, Thomas Jefferson University, Philadelphia, PA; 4 Department of Cancer Biology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA; 5 Dipartimento di Medicina Sperimentale e Patologia, Universita degli Studi "La Sapienza," Roma, Italy; 6 Ricerca e Diagnostica San Raffaele, Milano, Italy; 7 Universita Vita-Salute San Raffaele, Milano, Italy.
aAddress correspondence to this author at: Genomic Unit for the Diagnosis of Human Pathologies, DIBIT2, San Raffaele Scientific Institute, Via Olgettina 60 Milan, 20132 Milan, Italy. Fax 0039 02 26434351; e-mail cremonesi.laura{at}hsr.it.
Background: Methods are needed to analyze small amounts of samples for variation in disease-causing genes. One means is to couple the sensitivity and multiplexing capability of the ligation detection reaction (LDR) with the use of simple glass slides specifically functionalized with a novel polymer coating to enhance sensitivity.
Methods: We developed an array-based genotyping assay based on glass slides coated with copolymer (N,N-dimethylacrylamide, N,N-acryloyloxysuccinimide, and 3-(trimethoxysilyl)propyl methacrylate). The assay consists of an LDR with genomic DNA followed by a universal PCR (U-PCR) of genomic DNA–templated LDR product. The LDR occurs in the presence of 3 primers for each sequence variant under investigation: 2 distinguishing primers (allele specific and perfectly complementary to wild-type and mutant alleles) and 1 common locus-specific primer. The 2 allele-specific primers have different capture sequences for binding different complementary probes on a tag array. The LDR product templated from genomic DNA is made fluorescent during the U-PCR via incorporation of a Cy5-labeled universal primer into all LDR products; detection occurs on the coated glass slides.
Results: The assay was designed to detect 7 prevalent mutations in the β-globin gene (HBB, hemoglobin, beta) in a multiplex format, and signals for the different alleles are detected by their fluorescence. The assay was applied to 40 genomic DNA samples from both control individuals and patients with known β-thalassemia mutations. Results show good correspondence between the patients genotypes as assessed by DNA sequence analysis and those generated from the LDR assays.
Conclusions: The developed technology allows accurate identification of sequence variants in a simple, cost-effective way and offers good flexibility for scaling to other applications with different numbers of single-nucleotide polymorphisms or mutations to be detected.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |